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We investigated the effect of hydroxyl substituted chalcone (1a) and some chalcone analogues (1b–
d) on isolated rat liver mitochondria to gain new insights into the cytotoxic mechanism of these
compounds. We observed an inhibitory effect on phosphorylation and the partial uncoupling of
compounds 1a and 1d. Increased radical generation and possible covalent interaction of the com-
pounds with cellular thiols resulted in glutathione (GSH) depletion and modulation of the investi-
gated mitochondrial activities. Disruption of interconnected mechanisms as electron transport
chain and energetic metabolism, ROS production and insufﬁciency of antioxidant defensive system
could lead to induction of cell death.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Chalcones are intermediary compounds of the biosynthetic
pathway of a very large and widespread group of plant constitu-
ents known collectively as ﬂavonoids [1]. Chalcones have been
shown to possess antioxidant, oxygen scavenging, and anti-inﬂam-
matory properties in a variety of experimental systems [2,3]. Koh-
no et al. [4] found evidence that chalcone is converted to
hydroxylated derivatives with estrogenic activity.
Among the naturally occurring chalcones [5] and their synthetic
analogues [6,7] several compounds displayed cytotoxic (cell
growth inhibitor) activity towards cultured tumor cells. Chalcones
are also effective in vivo as cell proliferating inhibitors, anti-tumor
promoting and chemopreventive agents [5–7]. Chalcones, as a,b-
unsaturated carbonyl compounds, have a marked afﬁnity for thiols
in contrast to amines [6]. Since a number of clinically useful anti-
cancer drugs have genotoxic effects due to their interaction with
the amino groups of nucleic acids, chalcones may be devoid of this
important side effect [6,7].
Recently we have investigated in vitro antineoplastic activity of
several synthetic chalcones and cyclic chalcone analogues. The
compounds were evaluated against P388, L1210, Molt 4/C8 andchemical Societies. Published by E
edical Chemistry, Biochemis-
Šafárik University, Tr. SNP 1,
9.
vá-Kubálková).CEM cells as well as against approximately 60 further human tu-
mor cell lines from nine different neoplastic diseases [8–10].
Among the compounds investigated E-2-(40-X-benzylidene)-1-
benzosuberones (Fig. 1, n = 3) had the greatest tumor toxicity.
Structure–activity studies demonstrated that cytotoxicity of the
cyclic chalcone analogues were inﬂuenced by the shape of the mol-
ecules [8–10]. Besides the documented tumor cytotoxic effects,
some of the above cyclic chalcone analogues were found to display
outstanding CYP1A inhibitor activity [11,12]. Their speciﬁc chemi-
cal structure renders them to be powerful inducers of the phase 2
family of detoxifying enzymes [13]. Accordingly, the compounds
represent prototypes of molecules displaying both tumor cytotoxic
and cytoprotective (chemopreventive) effects.
The cytotoxic effect of a,b-unsaturated carbonyl compounds are
frequently associated with their expected reactivity with the
essential thiol groups in the living organisms [6,7,14,15]. Such a
reaction can alter intracellular redox status (redox signaling),
which can modulate processes such as DNA synthesis, enzyme
activation, selective gene expression, and regulation of the cell cy-
cle [16]. An important feature of the mitochondrial function of the
cell is an interrelationship between three essential cellular pro-
cesses: oxidative phosphorylation, generation of reactive oxygen
species, and initiation of physiological cell death (apoptosis) via
mitochondrial permeability transition pores [17]. Accordingly,
modiﬁcation of mitochondrial functions by xenobiotics may con-
tribute to their cytotoxic and antineoplastic activities.lsevier B.V. All rights reserved.
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Fig. 1. Chemical structure of the chalcones investigated.
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oxygen species (ROS) are generated. Their administration to vari-
ous xenobiotics may elevate ROS production [18]. The reactive
oxygen species of primary biologic importance include superoxide
(O2 ), hydroxyl radicals (OH
) and hydrogen peroxide (H2O2). Cell
damage occurs when there is an increased generation of reactive
oxygen species or a relative shortage of antioxidant molecules
[19]. Many of the stimuli that lead to apoptosis are associated with
the generation of ROS [20].
As a continuation of our previous studies [15] focusing on the
effect of chalcones on mitochondrial respiratory functions, in the
present study the effect of four hydroxyl substituted chalcone
(1a) and chalcone analogues (1b–d) on isolated rat liver mitochon-
dria was investigated. Characterization of mitochondrial respira-
tory functions on enzyme activities as well as redox status of
mitochondria administered to compounds of subcytotoxic doses
was investigated. We studied the effect of the compounds on the
reduced glutathione (GSH) content of the exposed mitochondria
and characterized in vitro reactivity of the compounds with GSH.
Since oxidation of hydroxyl-substituted xenobiotics could generate
reactive oxygen species (ROS), the compounds could cause oxida-
tive stress as a result of such a series of reactions [18]. To test this
possibility, we have investigated time-dependence of in vitro anti-
oxidant (hydroxyl radical scavenger) capacity of the compounds by
means of the Fenton-reaction-initiated degradation of 2-deoxyri-
bose [14].
2. Materials and methods
4-Hydroxychalcone (1a) and its cyclic derivatives (1b–d) were
synthesized and puriﬁed as described before [21]. Their structures
were characterized by IR and NMR spectroscopy. The purity of the
compounds was checked by thin layer chromatography (TLC) and
gas chromatography (GC) methods. Other chemicals used were of
the analytical grade available and, if otherwise not speciﬁed, pur-
chased from Sigma–Aldrich or Serva (Heidelberg, Germany). Com--80
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Fig. 2. Effect of hydroxychalcone derivatives 1a–d on mitochondrial functions.
(Results are calculated as the relative percentage of changes compared to the values
of the control group). *Mean, signiﬁcance P < 0.05.pounds 1a–d were dissolved in dimethyl sulfoxide (DMSO)
immediately before use.
Male Wistar rats (Velaz, Praha, Czech Republic) weighing 200–
250 g were used. Adhering to procedures approved by the Univer-
sity of Košice Animal Care and Use Committee, the animals were
sacriﬁced by cervical displacement and decapitation.
Liver mitochondria were isolated from male Wistar rats using
the method by Johnson and Lardy [22]. Mitochondrial protein
was determined according Lowry after Hartree’s modiﬁcation [23].
Polarographic measurement of oxygen consumption of isolated
mitochondria was carried out with a Clark electrode (WTW oxi 325
(Germany)) at the experimental temperature of 25 C. Measure-
ments were carried out in respiratory medium (80 mM KCl,
300 mM KH2PO4, 300 mM K2HPO4, 15 mM TRIS–HCl, 6 mM MgCl2,
0.78 mM EDTA, pH 7.4) supplemented with 70 nmol of chalcone
per mg of mitochondrial protein, 50 mM sodium succinate,
0.5 mM ADP and 20 mg/ml mitochondrial protein. The test com-
pounds were added in dimethyl sulfoxide (DMSO), a dose that
did not affect control rates of respiration. The respiratory rate is ex-
pressed as oxygen in nmol of oxygen consumed min1 mg1 of
mitochondrial protein [24]. Respiratory control ratio (RCR) was
determined as a ratio between oxygen consumption in state 3
(with addition of ADP) and state 4 (after exhaustion of ADP).
The activity of glutathione reductase (E.C.1.6.4.2) was deter-
mined according to Carlberg and Mannervik [25], and glutathione
peroxidase (E.C. 1.11.1.9) by the method of Flohe and Gunzler [26].
Reactivity of chalcones 1a–d with reduced glutathione (GSH)
was studied by the method described before [15]. The reaction
mixtures were kept in water bath (37 C and 50 C) and the pro-
gress of the reactions was followed by thin layer chromatography
(TLC) on Kieselgel F254 plates. The developing solvent used was n-
butanol:acetic acid:water (40:10:20, v/v %).
Determination of reduced glutathione in mitochondria (GSH)
was performed by the modiﬁed method of Abukhalaf et al. [27].
HPLC analyses were performed on LC-10ADVP liquid chromato-
graph (Schimadzu, Kyoto, Japan) equipped with an RF-10AXL ﬂuo-
rescence detector (Schimadzu). The elution gradient proﬁle was
as follows: 0 min: 0.5% ACN, 1–5 min: 10% ACN, 6–15 min.: 5%
ACN.
Investigation of the antioxidant capacity of chalcones 1a–d was
performed as described before [14]. Quercetin (200 lM) was used
as reference antioxidant. Each value is the average of three inde-
pendent measurements.
Results are presented as mean ± S.D. of at least three indepen-
dent experiments. Statistical signiﬁcance was determined by Stu-
dent’s t-test with P < 0.05 level considered as signiﬁcant.3. Results
The results of the present study demonstrate that the investi-
gated compounds are able to modify the mitochondrial activity
of the cell. Two of the selected compounds (1a and 1b) displayed
an inhibitory effect on both the ADP-stimulated respiration (state
3) and the controlled respiration (state 4) (Table 1). The six-mem-
bered analogue 1c did not affect either mitochondrial function. On
the contrary, compound 1d had no effect on state 3 respiration,
however, increased the rate of oxygen consumption after ADP
exhaustion (state 4) by 65.0% (Fig. 2).
Respiratory control ratio (RCR) was signiﬁcantly decreased by
the compounds 1a, 1b and 1d by 27.1%, 27.1% and 40.5%, respec-
tively (Table 1).
Reactivity of the compounds towards cellular thiols was inves-
tigated under cell-free conditions. Thin layer chromatographic
(TLC) analysis of 1:10 molar mixtures of chalcones and GSH incu-
bated at pH 7.4 or pH 9.0 at 50 C indicated the formation of
Table 1
Respiratory functions of mitochondria exposed to compounds 1a–d.
O2 consumption in state
4 (nmol O2
min1 mg1p)
O2 consumption in state
3 (nmol O2
min1 mg1p)
RCR
Control 21.84 ± 2.71 53.53 ± 0.35 2.47 ± 0.32
1a 13.43 ± 2.44* 21.96 ± 2.14* 1.80 ± 0.43*
1b 12.20 ± 2.24* 21.96 ± 2.14* 1.80 ± 0.43*
1c 26.60 ± 3.25 54.67 ± 3.84 2.06 ± 0.07
1d 36.05 ± 3.78* 52.86 ± 10.91 1.47 ± 0.34*
* Mean, signiﬁcance P < 0.05.
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peptide (GSH) moiety of them even after 2-h incubation. Similar
adduct formation could be detected when the incubations were
carried out at pH 9.0 at 37 C. On the other hand, no adduct forma-
tion could be detected in incubations carried out at pH 7.4 at 37 C.
Determination of reduced glutathione (GSH) content of incuba-
tions free of adduct formation did not indicate in vitro redox reac-
tion between the reactants.
Determination of reduced glutathione (GSH) levels of mito-
chondria exposed to the compounds tested was performed by
HPLC technique. On exposure of mitochondria to any of the tested
compounds resulted in reduction of GSH levels compared to that of
the DMSO-treated control experiments. Parallel to the reduction of
the cellular GSH levels increased glutathione peroxidase (GPx) and
glutathione reductase (GR) activities could be observed (Table 2).
Antioxidant capacity and possible pro-oxidant action of the
compounds were tested by measurement of time-dependence of
Fenton-reaction-initiated degradation of 2-deoxyribose [14]. Fen-
ton-reaction-initiated degradation of 2-deoxyribose may result
from an attack of hydroxyl radicals (HO), which results in the for-
mation of TBA-reactive substances with an absorption maximum
of 532 nm. As it is shown in Table 2, all the compounds tested dis-
played antioxidant activity (HO scavenging) at the 20-, 120- and
240-min time points.
4. Discussion
The mitochondrial electron transport chain is the source of con-
stantly forming reactive oxygen species [28]. Exogenous sources
could lead to increased or decreased production of reactive oxygen
species and display a toxic or protective effect, respectively. Atten-
tion was paid to select and investigate 40-hydroxychalcone (1a)
and its cyclic analogues (1b–d) due to their possible redox proper-
ties that can manifest in an antioxidant/pro-oxidant effect.
The results of the present study demonstrate that the investi-
gated compounds are able to modify the energy-linked functions
of the cells. In the selected concentrations 1a and 1b displayed
an inhibitory effect on ADP-stimulated respiration (state 3) in
59.0% each (Table 1). A decrease in oxygen consumption in the
presence of added ADP (state 3) is indicative of the inhibition ofTable 2
Reduced glutathione (GSH) content, glutathione peroxidase (GPx), glutathione reductase (
GSH content of mitochondria
(nmol/mgp)
GPx (U/
mgp)
GR (kat/kgp) An
[2
Control 11.69 ± 2.56 0.43 ± 0.12 94.36 ± 12.30 0.
1a 9.19 ± 2.24 0.76 ± 0.13* 147.50 ± 17.29* 0.
1b 5.62 ± 2.05* 0.62 ± 0.21 159.72 ± 20.19* 0.
1c 9.67 ± 1.83 0.73 ± 0.22 186.00 ± 29.09* 0.
1d 6.86 ± 2.88* 0.69 ± 0.26 124.62 ± 15.83* 0.
Quercetine – – – 0.
a The antioxidant capacity was determined by degradation on deoxyribose with the ini
* Mean, signiﬁcance P < 0.05.mitochondrial electron transfer chain [29,30]. Since the com-
pounds signiﬁcantly reduced the controlled respiration (state 4)
as well, the decreased respiratory control ration (RCR) suggested
a phosphorylation inhibitory effect or partial uncoupling of the
compounds (Table 1). This latter effect could be the result of the
lipophilic weak acid character of the compounds [31,32].
On the other hand, compounds 1c and 1d, had no effect on state
3 respiration, however, it increased the rate of oxygen consump-
tion (respiratory burst) after ADP exhaustion (state 4) by 21.8%
and 67.1%, respectively. Respiratory control ration (RCR) was re-
duced by 16.6% and 40.5% in the case of 1c and 1d, respectively
(Table 1). Since auto-oxidation of the compounds could not be
responsible for the observed oxygen consumption, the consumed
oxygen should be the substrate of the mitochondrial electron
transfer of the mitochondrial activity [29]. Such an effect can in-
crease the mitochondrial level of reactive oxygen species (ROS)
that can initiate a series of biochemical events, involving cell death
[18,33].
To keep reactive oxygen species production in balance, antiox-
idant defensive systems such as enzymatic removal of reactive
oxygen species and application of potent radical scavengers are ac-
tive. Several chalcones have been reported to display antioxidant
activity [6,7]. On the other hand, a variety of chalcones were found
to display antibacterial, antifungal, antiviral, and tumor cytotoxic
activities [5–7]. There is also evidence that shows some chalcones
to exhibit in vitro mutagenicity [6]. It is presumed that the toxic ef-
fects of the compounds might be due to their pro-oxidant activities
[5–7].
To test this possibility we have investigated the in vitro antiox-
idant capacity of the compounds by means of the Fenton-reaction-
initiated degradation of 2-deoxyribose. Fenton-reaction-initiated
degradation of 2-deoxyribose is thought to be the result of attack
of hydroxyl radicals (HO), which results in the formation of TBA-
reactive substances with an absorption maximum of 532 nm
[15]. As shown in Table 2, all the compounds investigated dis-
played a continuous antioxidant (HO scavenging) activity at the
investigated 20-, 120- and 240-min time points; i.e. the com-
pounds reduced the formation of TBA-reactive deoxyribose degra-
dation products.
Glutathione peroxidase (GPx) has a well-established role in pro-
tecting cells against oxidative injury by giving adaptive response to
oxidative stress conditions. GPx is non-speciﬁc for hydrogen perox-
ide and the lack of such substrate speciﬁcity results in a range of
substrates from hydrogen peroxide to organic hydrogen peroxides
[34]. An increase observed in GPx activities may be considered as a
result of ROS production that can be accompanied by mitochon-
drial damage (Table 2). Free radical production is one of the path-
ogenic mechanisms leading to apoptosis [20].
Cytotoxic effect of a,b-unsaturated carbonyl compounds are
frequently associated with the expected reactivity of the
compounds with the essential thiol groups in the living organisms
[6,7]. To study such reactivity, the compounds were allowed to re-
act with reduced glutathione (GSH), the main soluble cellular thiol,GR) activity of mitochondria and antioxidant capacity data of compounds 1a–d.
tioxidant capacitya
0 min]
Antioxidant capacitya
[120 min]
Antioxidant capacitya
[240 min]
765 ± 0.020 0.722 ± 0.020 0.740 ± 0.020
708 ± 0.024 0.637 ± 0.029 0.693 ± 0.023
613 ± 0.008 0.605 ± 0.018 0.657 ± 0.020
645 ± 0.039 0.620 ± 0.007 0.668 ± 0.001
610 ± 0.064 0.589 ± 0.036 0.598 ± 0.049
291 ± 0.010 0.315 ± 0.08 0.315 ± 0.024
tiation of Fenton reaction. Further experimental details are described in ‘‘Section 2”.
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compound showed intrinsic reactivity towards GSH at higher pH
values (pH 9.0) and about physiological pH values (pH 7.4) at a
higher temperature (50 C). An analysis of GSH content of the ad-
duct-free incubations did not indicate any measurable in vitro re-
dox reactivity of the compounds towards GSH.
In order to investigate whether the compounds can affect the
cellular thiol status of the mitochondria, the reduced glutathione
(GSH) level was determined. Under cellular conditions chalcones
can modify the thiol status by enzyme-catalyzed conjugation
and/or by oxidation of the reduced thiols to the respective disul-
ﬁdes [13,35]. On exposure of mitochondria to the compounds sub-
stantial reduction of the GSH level compared to the control could
be detected in each case (Table 2). The observation could be the
consequence of increased formation of ROS and a different gluta-
thione-S-transferase-catalyzed reactivity of the compounds with
GSH [35]. Simultaneously with the increased oxidative stress indi-
cated by the increased GPx levels, increased glutathione reductase
(GR) activity could also be observed (Table 2).
In conclusion, it was demonstrated that compounds 1b and 1d
displayed a pronounced effect on the modulation of mitochondrial
respiratory functions. Phosphorylation inhibitory effect or partial
uncoupling of the compounds resulted in stimulation of mitochon-
drial activity and increased formation of ROS. Increased formation
of ROS and possible covalent interaction of the compounds with
cellular thiols resulted in glutathione (GSH) depletion and inhibi-
tion or modulation of the investigated mitochondrial activities.
The disruption of interconnected mechanisms of the electron
transport chain and energetic metabolism in mitochondria, high
production of ROS and insufﬁciency of the antioxidant defensive
system could lead to the induction of cell death via the mitochon-
drial apoptotic pathway [20].
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